ASTRO Members Elect Dr. Beth Erickson as President-Elect

The American Society for Radiation Oncology (ASTRO) has elected Beth Erickson, MD, FASTRO, as its next president-elect, along with four new officers who will join the Society's Board of Directors beginning September 29 during ASTRO's 68th Annual Meeting in Boston.

Dr. Erickson, the J. Frank and Vera B. Wilson Professor of Radiation Oncology at the Medical College of Wisconsin, serves as chief of brachytherapy services and specializes in gynecologic, gastrointestinal and ocular cancers. She is internationally recognized for her expertise in brachytherapy and image-guided treatment planning.

An active ASTRO leader, Dr. Erickson previously served as Education Council Chair and led development of the Society's clinical guideline for endometrial cancer. She will serve as president-elect before assuming the presidency in September 2027.

"ASTRO is at our strongest when every member of the radiation oncology team can find meaningful ways to participate and grow throughout their career," Dr. Erickson said. "Education has long been one of our greatest strengths, and it will be essential as our field continues to evolve. As ASTRO President, I will be committed to showing patients and the broader medical community what radiation therapy can achieve, while advocating for fair reimbursement policies that support excellent care."

Dr. Erickson said her priorities include expanding educational opportunities, supporting research through grant training and funding, increasing awareness of radiation therapy's curative potential, and advocating for reimbursement policies that preserve patient and physician decision-making while ensuring access to guideline-concordant care.

ASTRO members also elected four council vice chairs to the Board of Directors:

• Indrin Chetty, PhD, FASTRO, was elected Clinical Affairs and Quality Council vice chair. A professor and vice chair of research at Cedars-Sinai Medical Center, Dr. Chetty will help guide radiation oncology quality and safety initiatives, including standards for adopting artificial intelligence and other emerging technologies.

• Kenneth Rosenzweig, MD, FASTRO, was elected Education Council vice chair. Chair of radiation oncology at the Icahn School of Medicine at Mount Sinai, Dr. Rosenzweig will focus on professional development across all career stages and preparing the specialty for a changing healthcare landscape.

• John Suh, MD, FASTRO, was elected Government Relations Council vice chair. A professor and enterprise chair of radiation oncology at Cleveland Clinic, Dr. Suh will help lead advocacy efforts supporting the Radiation Oncology Case Rate (ROCR) Act, reimbursement policies that protect patient access to care, and federal research funding.

• Gita Suneja, MD, FASTRO, was elected Healthcare Access and Community Engagement Council vice chair. A professor at the University of Utah's Huntsman Cancer Institute, Dr. Suneja will focus on reducing barriers to radiation therapy, strengthening community engagement, and expanding mentorship and research opportunities for trainees and early-career professionals.

The newly elected officers will help lead ASTRO, which represents more than 10,000 physicians, medical physicists, biologists, radiation therapists and other professionals dedicated to advancing radiation therapy for patients with cancer and other diseases.